@prefix dc: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix hgnc: . @prefix proteinModification: . @prefix psimod: . @prefix mesh: . @prefix occursIn: . @prefix hasAnnotation: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:variantOf hgnc:6126; a proteinModification:, psimod:00696 . sub:_2 occursIn: mesh:D002462, mesh:D052437, species:9606; hasAnnotation: sub:_3; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:7733; a rdf:Statement . sub:_3 dc:subject "TextLocation"; rdf:value "Review" . sub:assertion rdfs:label "a(CHEBI:\"okadaic acid\") -> p(HGNC:IRS2,pmod(P,S))" . } sub:provenance { beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds."; dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved."; dce:title "BEL Framework Small Corpus Document"; dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License"; pav:authoredBy sub:_5; pav:version "1.6" . sub:_4 prov:value """Primary brown adipocytes pretreated with this compound before insulin stimulation showed a marked increase in IRS-1/2 serine phosphorylation with a concomitant decrease in tyrosine phosphorylation of these molecules and a partial inhibition of IRS-1- and IRS-2-associated PI 3-kinase activity [53]."""; prov:wasQuotedFrom pubmed:15777261 . sub:_5 rdfs:comment "support@belframework.org"; rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:15777261; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dc:created "2014-07-03T14:29:32.539+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }